David Pepperl

---

David Pepperl serves as a Nonclinical Advisor to Cartago Biotech, providing strategic guidance on development planning, regulatory readiness, and risk assessment across the company’s therapeutic programs. He brings more than 25 years of experience advising biotechnology and pharmaceutical companies on nonclinical development and regulatory strategy. He has supported a wide range of programs across biologics and advanced therapies, with a particular focus on oncology, immunotherapy, and infectious disease.

Over the course of his career, he has held senior consulting and leadership roles in nonclinical development, including more than two decades at Biologics Consulting, where he has advised numerous early- and mid-stage companies on development strategy and regulatory interactions with the U.S. Food and Drug Administration. 

At Cartago Biotech, he contributes his deep experience, regulatory insight, and strategic perspective to support disciplined execution and informed decision-making as the company advances innovative therapies.